EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development

Janet K Yamamoto, Lekshmi K Edison iD, Dawne K Rowe-Haas, Tomomi Takano iD, Chen Gilor, Chiquitha D Crews iD, Apichai Tuanyok iD, Ananta P Arukha, Sayaka Shiomitsu iD, Heather D S Walden, Tsutomu Hohdatsu, Stephen M Tompkins iD und 3 weitere

Viruses · 2023

DOI: 10.3390/v15040914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Janet K Yamamoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative, Diagnostic, and Population Medicine (CDPM), College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, …. Hauptthemen laut MEDLINE: Coronavirus, Feline, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: J.K.Y. Miscellaneous Donors Account, SK CVM Startup fund 211.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study was initiated when our specific-pathogen-free laboratory toms developed unexpectedly high levels of cross-reactive antibodies to human SARS-CoV-2 (SCoV2) receptor binding domain (RBD) upon mating with feline coronavirus (FCoV)-positive queens. Multi-sequence alignment analyses of SCoV2 Wuhan RBD and four strains each from FCoV serotypes 1 and 2 (FCoV1 and FCoV2) demonstrated an amino acid sequence identity of 11.5% and a similarity of 31.8% with FCoV1 RBD (12.2% identity and 36.5% similarity for FCoV2 RBD). The sera from toms and queens cross-reacted with SCoV2 RBD and reacted with FCoV1 RBD and FCoV2 spike-2, nucleocapsid, and membrane proteins, but not with FCoV2 RBD. Thus, the queens and toms were infected with FCoV1. Additionally, the plasma from six FCoV2-inoculated cats reacted with FCoV2 and SCoV2 RBDs, but not with FCoV1 RBD. Hence, the sera from both FCoV1-infected cats and FCoV2-infected cats developed cross-reactive antibodies to SCoV2 RBD. Furthermore, eight group-housed laboratory cats had a range of serum cross-reactivity to SCoV2 RBD even 15 months later. Such cross-reactivity was also observed in FCoV1-positive group-housed pet cats. The SCoV2 RBD at a high non-toxic dose and FCoV2 RBD at a 60–400-fold lower dose blocked the in vitro FCoV2 infection, demonstrating their close structural conformations essential as vaccine immunogens. Remarkably, such cross-reactivity was also detected by the peripheral blood mononuclear cells of FCoV1-infected cats. The broad cross-reactivity between human and feline RBDs provides essential insights into developing a pan-CoV vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronavirus, FelineCOVID-19CatsAnimalsHumansSARS-CoV-2Antibodies, ViralLeukocytes, MononuclearSerogroupAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

SARS-CoV-2cross-reactivityfeline coronavirusreceptor binding domain

Substanzen

Antibodies, ViralAntibodies, NeutralizingSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Comparative, Diagnostic, and Population Medicine (CDPM), College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Laboratories of Comparative Immunology & Virology for Companion Animals, CDPM, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
  • Laboratory of Veterinary Infectious Disease, Department of Veterinary Medicine, Kitasato University, Tokyo 108-8641, Japan.
  • Department of Small Animal Clinical Science, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.

ORCID-Profile: Lekshmi K Edison, Tomomi Takano, Chiquitha D Crews, Apichai Tuanyok, Sayaka Shiomitsu, Stephen M Tompkins, John G Morris, Bikash Sahay

Förderung

  • J.K.Y. Miscellaneous Donors Account
  • SK CVM Startup fund 211

Zitieren

APA

Yamamoto, J. K., Edison, L. K., Rowe-Haas, D. K., Takano, T., Gilor, C., Crews, C. D., Tuanyok, A., Arukha, A. P., Shiomitsu, S., Walden, H. D. S., Hohdatsu, T., Tompkins, S. M., Morris, J. G., Sahay, B., & Kariyawasam, S. (2023). Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. https://doi.org/10.3390/v15040914

Vancouver

Yamamoto JK, Edison LK, Rowe-Haas DK, Takano T, Gilor C, Crews CD, et al. Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. 2023. doi:10.3390/v15040914

BibTeX
@article{Yamamoto2023,
  author = {Yamamoto, Janet K and Edison, Lekshmi K and Rowe-Haas, Dawne K and Takano, Tomomi and Gilor, Chen and Crews, Chiquitha D and Tuanyok, Apichai and Arukha, Ananta P and Shiomitsu, Sayaka and Walden, Heather D S and Hohdatsu, Tsutomu and Tompkins, Stephen M and Morris, John G and Sahay, Bikash and Kariyawasam, Subhashinie},
  title = {Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040914}
}
Kostenlos starten →